Month: June 2020

SAN FRANCISCO, June 11, 2020 (GLOBE NEWSWIRE) — Stitch Fix, Inc. (NASDAQ: SFIX), the leading online personal styling service, today announced that Mike Smith, President, COO, and interim CFO of Stitch Fix, is scheduled to participate in a virtual fireside chat at the Wells Fargo “Bricks to Clicks” Digital Conference on Thursday, June 25 at 1:25 P.M. ET / 10:25 A.M. PT.About Stitch FixStitch Fix is an online personal styling service that is reinventing the shopping experience by delivering one-to-one personalization to our clients through the combination of data science and human judgment. Stitch Fix was founded in 2011 by CEO Katrina Lake. Since then, we’ve helped millions of women, men, and kids discover and buy what they love through personalized selections of apparel, shoes, and accessories, curated by Stitch Fix stylists and...

SUWANEE, Ga., June 11, 2020 (GLOBE NEWSWIRE) — Digirad Corporation (Nasdaq: DRAD; DRADP) (“Digirad” or the “Company”), a diversified holding company with three divisions: Healthcare, Building & Construction, and Real Estate & Investments, announced today that KBS Builders, Inc. (“KBS”) has signed a $2.0 million contract to manufacture housing units for military veterans. KBS is the Maine-based modular building manufacturing business of the Company’s Building & Construction division.KBS’s contract is part of a larger housing project that involves the renovation and expansion of an existing mixed-use building in downtown Quincy, MA. The existing structure consists of ground level retail, commercial, and restaurant space with sixteen residential units for military veterans. The expansion plan contemplates the retrofitting...

Novel BIV201 Formulation Shows Significant Improvements Over Industry TerlipressinPrefilled Syringe May Significantly Extend Market Protection Beyond Orphan Drug ExclusivitySANTA MONICA, Calif., June 11, 2020 (GLOBE NEWSWIRE) — BioVie Inc. (OTCQB: BIVI) (“BioVie” or “Company”), a clinical-stage company developing innovative drug therapies for liver disease, announced today that following the company’s successful Phase 2a study, it has received guidance from the US Food and Drug Administration (“FDA”) regarding the next clinical trial design for BIV201 (continuous infusion terlipressin) in patients with refractory ascites due to liver cirrhosis. The Company plans to commence a randomized 24-patient Phase 2 study this year, to be followed by a larger pivotal Phase 3 clinical trial targeted to begin the first half 2021. The FDA has...

HOUSTON, June 11, 2020 (GLOBE NEWSWIRE) — Independent research company, Javelin Strategy & Research, with support from Cardtronics, conducted two new studies on cash to assess the strength and desirability of all payment options and to provide a window into consumer payment preferences within the U.S., both before and during the COVID-19 pandemic and economic downturn.In late 2019, Cardtronics commissioned an independently produced research report about cash usage in the U.S., which published in February 2020 as the 2020 Health of Cash Study. Earlier this year, Cardtronics commissioned Javelin to conduct a companion study to measure consumer sentiment toward cash and payments during the pandemic. Cardtronics summarized the results of these two studies in a white paper called Health of Cash Check-Up May 2020: A Study of Cash...

First Quarter 2020 Net Income of $20,000 ($0.01 per diluted share) v. $70,000 ($0.02 per diluted share) in Prior PeriodFirst Quarter EBITDA, As Adjusted, of $86,000 ($0.02 per diluted share) v. $121,000 ($0.03 per diluted share) in Prior Year PeriodHAUPPAUGE, N.Y., June 11, 2020 (GLOBE NEWSWIRE) — Orbit International Corp. (OTC PINK:ORBT) today announced results for the first quarter ended March 31, 2020.First Quarter 2020 vs. First Quarter 2019Net sales were $5,852,000, as compared to $6,492,000.Gross margin was 30.3%, as compared to 26.0%.Net income was $20,000 ($0.01 per diluted share), as compared to a net income of $70,000 ($0.02 per diluted share).Earnings before interest, taxes, depreciation and amortization, fair value adjustment on contingent liability and stock-based compensation (EBITDA, as adjusted) was $86,000 ($0.02...

AUSTIN, Texas, June 11, 2020 (GLOBE NEWSWIRE) — Vermillion, Inc. (Nasdaq: VRML), a bioanalytical-based women’s health company focused on ovarian cancer risk assessment, today announced a major rebranding to reflect the company’s continuing evolution towards becoming a comprehensive gynecologic health company, including a corporate name change to Aspira Women’s Health Inc effective today, June 11, 2020. The company’s common stock will trade on the Nasdaq Stock Market under the new ticker symbol “AWH” effective June 12, 2020.Over the past 12 months, Aspira Women’s Health has established its foundation as the market leader for ovarian cancer risk assessment while beginning product development to expand into large benign gynecologic disease markets. The company’s goal is to serve the large pelvic mass market, 20 million women in the...

TORONTO, June 11, 2020 (GLOBE NEWSWIRE) — Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that its Board of Directors has granted a total of 1,430,000 stock options to directors, officers and certain consultants pursuant to the Company’s stock option plan and the requirements of the TSX Venture Exchange (TSXV).The total grant of 980,000 options to the directors and officers represents remuneration for serving on the board and managing the Company’s affairs for the annual periods ending April 1, 2020 and April 1, 2021.Each of the director and officer stock options is exercisable into one common share of the Company for a period of ten years, exercisable at $1.48 per share. The grant of options will be subject to all necessary regulatory approvals.About Arch BiopartnersArch...

VANCOUVER, British Columbia, June 11, 2020 (GLOBE NEWSWIRE) — Novo Resources Corp. (“Novo” or the “Company”) (TSX-V: NVO; OTCQX: NSRPF) is pleased to announce that it has entered into a binding terms sheet to acquire three exploration licences (the “Mt. Elsie Project”) comprising an area of approximately 19 km2 located 75 km north-east of the town of Nullagine, Western Australia and adjacent to numerous Novo wholly-owned tenements (please see figure 1 below) (the “Acquisition”). The Acquisition is conditional upon receipt of any consents or approvals required under the Mining Act 1978 (WA) and the acceptance of the TSX Venture Exchange (the “Conditions”).Subject to satisfaction of the Conditions, the Company will issue an aggregate 324,506 common shares (the “Consideration Shares”) and pay AU$100,000 in cash to the vendors of the...